Charles River Laboratories International earnings were -$69.2M for the trailing 12 months ending Jun 28, 2025, with N/A growth year over year. The latest CRL earnings report on Jun 28, 2025 announced Q2 2025 earnings of $52.3M, up 105.4% from last quarter. For the last reported fiscal year 2024 ending Dec 28, 2024, CRL reported annual earnings of $10.3M, with -97.8% growth.
Charles River Laboratories International Earnings Reports & History FAQ
What were Charles River Laboratories International's earnings last quarter?
On CRL's earnings call on Invalid Date, Charles River Laboratories International (NYSE: CRL) reported Q2 2025 earnings per share (EPS) of $1.06, up 39.43% year over year. Total CRL earnings for the quarter were $52.33 million. In the same quarter last year, Charles River Laboratories International's earnings per share (EPS) was $1.75.
Is Charles River Laboratories International profitable or losing money?
As of the last Charles River Laboratories International earnings report, Charles River Laboratories International is currently losing money. Charles River Laboratories International's net profit (also called net income) for the twelve months ending Jun 28, 2025 was -$67.04 million, a 115.18% decrease year over year.
What was CRL's earnings growth in the past year?
As of Charles River Laboratories International's earnings date in Invalid Date, Charles River Laboratories International's earnings has grown year over year. CRL earnings in the past year totalled -$69.23 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.